1 / 6

Intravenous Immunoglobulin (IVIG) Market Size, Demand, Analysis, On-Going Trends, Status, Forecast 2027 | Omrix Biopharm

The Global Intravenous Immunoglobulin (IVIG) market research report provides an insightful analysis of the current market, along with a futuristic perspective on the growth of the market.

thomasburnsrnd
Télécharger la présentation

Intravenous Immunoglobulin (IVIG) Market Size, Demand, Analysis, On-Going Trends, Status, Forecast 2027 | Omrix Biopharm

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Intravenous Immunoglobulin (IVIG) Market To Reach USD 15.67 Billion By 2026 www.reportsanddata.com

  2. Market Summary The Global Intravenous Immunoglobulin (IVIG) Market is forecast to reach USD 15.67 Billion by 2026, according to a new report by Reports and Data. Immunoglobulin refers to the breakdown of blood plasma that contains antibody. It is a procedure that is undertaken intravenously. It is a treatment of choice for patients with antibody deficiency. Immunoglobulins are highly complex entities, and they are very specific in their action. They are obtained from blood by fractionation process and purified for nontherapeutic and therapeutic applications. Different classes of immunoglobulin such as IgA, IgG, and IgM are used for the treatment of various neurological and immunological diseases. Primary factors for the growth of the market are an increase in the geriatric population, an increase in the number of hemophilic patients, enhancement in technology related to immunoglobulin production, and better purification techniques. North America dominated the market of Intravenous Immunoglobulin (IVIG). Increase in the level of awareness of these procedures and preference of clinicians to adopt these techniques is boosting the growth of the market in this region. Investment in the healthcare system by the government is also propelling the growth of the market. Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1442 www.reportsanddata.com

  3. Market Summary • Further key findings from the report suggest • Human IgG is expressed in the surface of mature B cells and is the most prevalent serum among all the other Immunoglobulin. It held the largest market share of 31% in the year 2018. • Immunoglobulin via intravenous procedure is majorly done in hospitals. It held a market share of 43% in the year 2018. • The market is segmented into hospital pharmacy and specialty pharmacy based on the distribution channel. • Kawasaki disease is forecasted to hold a market share of 14% in the year 2026. It is a rare childhood disease that inflames the blood vessels of the body. • People with the Immune Thrombocytopenic Purpura ITP disease have too few platelets in the blood. It is forecasted to have a CAGR of 8.1% during the forecast period. • Asia Pacific has the highest growth rate of 7.6% during the forecast period. Rising awareness is encouraging the growth of the market in the region. • Key participants include Omrix Biopharmaceuticals Ltd., Hualan Biological Engineering Inc., Shanghai RAAS Blood Products Co. Ltd., Behring GmbH, Option Care Enterprises, Inc., BioScrip, Inc, ADMA Biologics, Inc., CSL Ltd., Baxter International Inc., KedrionBiopharma Inc., Grifols S.A, LFB group, Octapharma AG, China Biologics Products, Inc., Biotest AG, and Takeda Pharmaceuticals, among others. • To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/intravenous-immunoglobulin-market www.reportsanddata.com

  4. Market Summary For the purpose of this report, Reports and Data have segmented into the global Intravenous Immunoglobulin (IVIG) Market on the basis of Type, Application, End Users, Distribution Channel, and Region: Type Outlook (Revenue, USD Billion; 2016-2026) IgG IgA IgM IgE IgD Application Outlook (Revenue, USD Billion; 2016-2026) Hypogammaglobulinemia Immunodeficiency Diseases Chronic Inflammatory Demyelinating Polyneuropathy Myasthenia Gravis Multifocal Motor Neuropathy ITP Guillain-Barre syndrome Kawasaki Diseases Others www.reportsanddata.com

  5. Market Summary End Users Outlook (Revenue, USD Billion; 2016-2026) Hospitals Clinics Homecare Others Distribution Channel Outlook (Revenue, USD Billion; 2016-2026) Hospital Pharmacy Specialty Pharmacy Regional Outlook (Revenue, USD Billion; 2016-2026) North America Europe Asia Pacific MEA Latin America www.reportsanddata.com

  6. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related